Delivery Order SPE2DB20D2014-SPE2DB24FB40J
Award Date
3/21/24
Potential Completion Date
3/22/24
Potential Value
$3.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order valued at $5,393.88 to Amerisourcebergen Drug Corp, a leading global pharmaceutical distributor, for the provision of Advair HFA 115-21 mcg inhalers. This delivery order, with a period of performance through April 2, 2024, is issued under an indefinite delivery contract (IDC) with a potential value of up to $999,999,999.00 that enables Amerisourcebergen to deliver a comprehensive range of pharmaceutical...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,562.04 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, to provide Advair HFA 115-21 MCG inhalers. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that was previously awarded to Amerisourcebergen Drug Corp by DLA for the provision of a comprehensive range of pharmaceutical...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,862.36 to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The contract is for the delivery of Advair HFA 230-21 MCG inhalers to support military treatment programs and facilities. The delivery order was issued under an existing indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug Corp, which has a...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Advair HFA 230-21 MCG Inhaler 12GM medication. The $3,975.72 contract has a performance period through March 26, 2024 and does not have a set-aside designation. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which is placed against a $999,999,999.00 indefinite delivery contract (IDC)...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Advair HFA 115-21 MCG inhalers. The $12,577.37 contract has a period of performance through March 22, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This award is associated with a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $24,567.14 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Advair HFA 230-21 mcg inhalers. This delivery order is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to $999,999,999.00, to deliver a comprehensive range of pharmaceutical products and medical supplies in support of military treatment...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide an Advair HFA 230-21 MCG inhaler with a potential value of $6,549.48. This order has a completion date of February 6, 2024 and was awarded on February 5, 2024. The place of performance is Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp is a for-profit organization that serves as a prime contractor to DLA, providing a...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Advair HFA 230-21 MCG Inhaler 12GM pharmaceutical products. The $1,987.86 contract has a completion date of February 1, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is issued under a larger $999,999,999.00 indefinite delivery contract (IDC)...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The $4,160.20 award is for the supply of Advair HFA 230-21 MCG Inhaler 12GM, a pharmaceutical product. The contract has a completion date of February 20, 2024 and was awarded on February 16, 2024. Amerisourcebergen Drug Corp serves as the prime contractor on this...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Advair HFA 230-21 mcg inhalers. The contract has a potential value of $1,356.29 and a performance period ending on January 31, 2024. AmerisourceBergen Drug Corp, a for-profit organization, is the prime contractor on this award, which is not designated as a set-aside contract. This delivery order contract is...